logo

Metal-Based Drugs

Metal-Based Drugs / Table of Contents

Table of Contents

Table of Contents

  • Metal-Based Drugs -
  • Special Issue
  • Volume 7
  • - Article ID 206192

Zinc(II) Complexes - A New Group of Non-Mutagenic Herpes Simplex Virus Inhibitors

Margarita Pesheva | Tatiana Varadinova
  • Metal-Based Drugs -
  • Special Issue
  • Volume 8
  • - Article ID 781386

New Boron Analogues of Pyrophosphates and Deoxynucleoside Boranophosphates

Kamesh Vyakaranam | Geeta Rana | ... | Bernard F. Spielvogel
  • Metal-Based Drugs -
  • Special Issue
  • Volume 6
  • - Article ID 140865

Radiorecovery Activity of Dicopper(II) Tetrakis(3,5-Diiso propylsalicylate) Includes Recovery of Radiation-Induced Loss of Body Mass and Impaired Mouse Locomotion

Renada D. Henderson | Timothy D. Henderson | ... | John R. J. Sorenson
  • Metal-Based Drugs -
  • Special Issue
  • Volume 5
  • - Article ID 842678

Synthesis and Radioprotective Activity of New Organosilicon and Germanium Compounds

Ghassoub Rima | Jacques Satgé | ... | Jean-Denis Laval
  • Metal-Based Drugs -
  • Special Issue
  • Volume 2
  • - Article ID 610368

A Spectroscopic Study on Binding to Rabbit Skeletal Muscle G-Actin

Juan Zou | Hong-Ye Sun | Kui Wang
  • Metal-Based Drugs -
  • Special Issue
  • Volume 8
  • - Article ID 587681

Transition Metal Ion Complexes of Schiff-bases. Synthesis, Characterization and Antibacterial Properties

Zahid H. Chohan | Asifa Munawar | Claudiu T. Supuran
  • Metal-Based Drugs -
  • Special Issue
  • Volume 7
  • - Article ID 216590

Hydroxynaphthoquinone Metal Complexes as Antitumor Agents X: Synthesis, Structure, Spectroscopy and In Vitro Antitumor Activity of 3-Methyl-Phenylazo Lawsone Derivatives and Their Metal Complexes Against Human Breast Cancer Cell Line MCF-7

Nikhil Gokhale | Subhash Padhye | ... | Robin Pritchard
  • Metal-Based Drugs -
  • Special Issue
  • Volume 1
  • - Article ID 469314

Degradation of Anthracycline Antitumor Compounds Catalysed by Metal Ions

Marina M. L. Fiallo | Hayet Tayeb-Bel Haj | Arlette Garnier-Suillerot
  • Metal-Based Drugs -
  • Special Issue
  • Volume 6
  • - Article ID 860860

Down-Regulation of Porcine Heart Diaphorase Reactivity by Trimanganese Hexakis(3,5-Diisopropylsalicylate),, and Down-Regulation of Nitric Oxide Synthase Reactivity by and

Billynda L. Booth | Eva Pitters | ... | John R. J. Sorenson
  • Metal-Based Drugs -
  • Special Issue
  • Volume 4
  • - Article ID 673476

Determination of Biotransformation Products of Platinum Drugs in Rat and Human Urine

Xia Tang | Jerry W. Hayes, II | ... | Katherine Tepperman
  • Metal-Based Drugs -
  • Special Issue
  • Volume 5
  • - Article ID 560748

In Vivo Nitric Oxide Synthase Inhibitors Can Be Deprived of This Activity: Unexpected Influence of the Tetrachloroplatinate(II) Counteranion. Crystal Structures of Bis(S-Methyl-Isothiouronium)-N,N′-Bis(3-Guanidinopropyl)Piperazinium and Hexamidinium Tetrachloroplatinates(II) Salts

Georges Morgant | Bernard Viossat | ... | Dung Nguyen Huy
  • Metal-Based Drugs -
  • Special Issue
  • Volume 3
  • - Article ID 241250

Cytotoxicity and Antineoplastic Activities of Alkylamines and Their Borane Derivatives

Iris H. Hall | Elaine Y. Tse | Rosallah A. Muhammad
  • Metal-Based Drugs -
  • Special Issue
  • Volume 1
  • - Article ID 913869

Analysis of Multidrug Transporter in Living Cells. Inhibition of P-glycoprotein-mediated Efflux of Anthracyclines by Ionophores

Marie-Nicole Borrel | Elene Pereira | ... | Arlette Garnier-Suillerot
  • Metal-Based Drugs -
  • Special Issue
  • Volume 8
  • - Article ID 845954

Interaction of Ruthenium(II)-dipyridophenazine Complexes with CT-DNA: Effects of the Polythioether Ancillary Ligands

Teresa M. Santos | João Madureira | ... | Vitor Félix
  • Metal-Based Drugs -
  • Special Issue
  • Volume 7
  • - Article ID 329107

Role of Vitamin D on the Inhibition of Gastrin Production After Cisplatin Treatment

Ying Wang | Surinder K. Aggarwal | Will Kopachik

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.